Literature DB >> 2962860

Structure and biologic properties of the atrial natriuretic peptides.

S P Adams1.   

Abstract

Since its discovery, ANF has provided multitudinous opportunities to explore its relationship to various biologic functions. Hundreds of publications investigating various aspects of this newly discovered hormone system have appeared. ANF exhibits a plethora of direct and indirect biologic activities that oppose the hypervolemic and hypernatremic effects exerted by the renin-aldosterone-angiotensin system. Additionally, ANF and ANF receptors are present in the central and peripheral nervous system, and ANF administered in the brain exerts striking effects relating to vasopressin and water consumption. It thus appears that ANF functions as a neurotransmitter or neuromodulator in consort with its direct peripheral actions. One may anticipate that continued research will uncover more interesting biology and elucidate the interplay between ANF and various control systems responsible for volume and electrolyte homeostasis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962860

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  4 in total

1.  Lesions of the hypothalamus and pituitary inhibit volume-expansion-induced release of atrial natriuretic peptide.

Authors:  J Antunes-Rodrigues; M J Ramalho; L C Reis; J V Menani; M Q Turrin; J Gutkowska; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Haemodynamic effects of atrial natriuretic peptide in hypoxic chronic obstructive pulmonary disease.

Authors:  T K Rogers; W Sheedy; J Waterhouse; P Howard; A H Morice
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

3.  Carotid-aortic and renal baroreceptors mediate the atrial natriuretic peptide release induced by blood volume expansion.

Authors:  J Antunes-Rodrigues; B H Machado; H A Andrade; H Mauad; M J Ramalho; L C Reis; C R Silva-Netto; A L Favaretto; J Gutkowska; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.

Authors:  J S Thompson; W Sheedy; A H Morice
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.